Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 17 entries
Sorted by: Best Match Show Resources per page
Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research

Lalanne C, Duracinsky M, Marcellin F, Lert F, Chassany O, Carrieri PM, Dray-Spira R, Spire B.
PMID: 27202516
Value Health. 2014 Nov;17(7):A681-2. doi: 10.1016/j.jval.2014.08.2542. Epub 2014 Oct 26.

No abstract available.

Cite
Lalanne C, Duracinsky M, Marcellin F, et al. Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA. Value Health. 2014;17(7):A681-2doi: 10.1016/j.jval.2014.08.2542.
Lalanne, C., Duracinsky, M., Marcellin, F., Lert, F., Chassany, O., Carrieri, P. M., Dray-Spira, R., & Spire, B. (2014). Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA. Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research, 17(7), A681-2. https://doi.org/10.1016/j.jval.2014.08.2542
Lalanne, C, et al. "Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA." Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research vol. 17,7 (2014): A681-2. doi: https://doi.org/10.1016/j.jval.2014.08.2542
Lalanne C, Duracinsky M, Marcellin F, Lert F, Chassany O, Carrieri PM, Dray-Spira R, Spire B. Confirmation of the Factor Structure of the Proqol-HIV Questionnaire to Assess Health-Related Quality of Life in PLWHA. Value Health. 2014 Nov;17(7):A681-2. doi: 10.1016/j.jval.2014.08.2542. Epub 2014 Oct 26. PMID: 27202516.
Copy Download .nbib Format: NLM
Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?.

Alimentary pharmacology & therapeutics

Chassany O, Duracinsky M.
PMID: 18638076
Aliment Pharmacol Ther. 2008 Aug 01;28(3):371-2. doi: 10.1111/j.1365-2036.2008.03704.x.

No abstract available.

Cite
Chassany O, Duracinsky M. Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?. Aliment Pharmacol Ther. 2008;28(3):371-2doi: 10.1111/j.1365-2036.2008.03704.x.
Chassany, O., & Duracinsky, M. (2008). Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?. Alimentary pharmacology & therapeutics, 28(3), 371-2. https://doi.org/10.1111/j.1365-2036.2008.03704.x
Chassany, O, and Duracinsky, M. "Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?." Alimentary pharmacology & therapeutics vol. 28,3 (2008): 371-2. doi: https://doi.org/10.1111/j.1365-2036.2008.03704.x
Chassany O, Duracinsky M. Is amitriptyline really effective in diarrhoea-predominant irritable bowel syndrome?. Aliment Pharmacol Ther. 2008 Aug 01;28(3):371-2. doi: 10.1111/j.1365-2036.2008.03704.x. PMID: 18638076.
Copy Download .nbib Format: NLM
Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream.

Therapeutic innovation & regulatory science

Reaney M, McHorney CA, Curtis B, Rydén A, Chassany O, Gwaltney C.
PMID: 30227051
Ther Innov Regul Sci. 2017 Jul;51(4):404-415. doi: 10.1177/2168479017701979. Epub 2017 Apr 04.

From humanistic, clinical, and economic perspectives, it is important to understand patients' health care attitudes and behavior. Of particular interest in defining the value of a pharmacologic therapy is medication adherence. A DIA workstream was convened to define medication...

Cite
Reaney M, McHorney CA, Curtis B, et al. Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream. Ther Innov Regul Sci. 2017;51(4):404-415doi: 10.1177/2168479017701979.
Reaney, M., McHorney, C. A., Curtis, B., Rydén, A., Chassany, O., & Gwaltney, C. (2017). Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream. Therapeutic innovation & regulatory science, 51(4), 404-415. https://doi.org/10.1177/2168479017701979
Reaney, Matthew, et al. "Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream." Therapeutic innovation & regulatory science vol. 51,4 (2017): 404-415. doi: https://doi.org/10.1177/2168479017701979
Reaney M, McHorney CA, Curtis B, Rydén A, Chassany O, Gwaltney C. Using Individual Experiences With Experimental Medications to Predict Medication-Taking Behavior Postauthorization: A DIA Study Endpoints Workstream. Ther Innov Regul Sci. 2017 Jul;51(4):404-415. doi: 10.1177/2168479017701979. Epub 2017 Apr 04. PMID: 30227051.
Copy Download .nbib Format: NLM
Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme Borreliosis.

Microorganisms

Raffetin A, Barquin A, Nguala S, Paoletti G, Rabaud C, Chassany O, Caraux-Paz P, Covasso S, Partouche H.
PMID: 34361950
Microorganisms. 2021 Jul 15;9(7). doi: 10.3390/microorganisms9071515.

BACKGROUND: Some subjective symptoms may be reported at all stages of Lyme borreliosis (LB) and may persist for several months after treatment. Nonspecific symptoms without any objective manifestation of LB are sometimes attributed by patients to a possible tick...

Cite
Raffetin A, Barquin A, Nguala S, et al. Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme Borreliosis. Microorganisms. 2021;9(7)doi: 10.3390/microorganisms9071515.
Raffetin, A., Barquin, A., Nguala, S., Paoletti, G., Rabaud, C., Chassany, O., Caraux-Paz, P., Covasso, S., & Partouche, H. (2021). Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme Borreliosis. Microorganisms, 9(7), . https://doi.org/10.3390/microorganisms9071515
Raffetin, Alice, et al. "Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme Borreliosis." Microorganisms vol. 9,7 (2021). doi: https://doi.org/10.3390/microorganisms9071515
Raffetin A, Barquin A, Nguala S, Paoletti G, Rabaud C, Chassany O, Caraux-Paz P, Covasso S, Partouche H. Perceptions, Representations, and Experiences of Patients Presenting Nonspecific Symptoms in the Context of Suspected Lyme Borreliosis. Microorganisms. 2021 Jul 15;9(7). doi: 10.3390/microorganisms9071515. PMID: 34361950; PMCID: PMC8304161.
Copy Download .nbib Format: NLM
Promoting HIV, Hepatitis B Virus, and Hepatitis C Virus Screening Among Migrants With a Language Barrier: Protocol for the Development and Evaluation of an Electronic App (Apidé).

JMIR research protocols

Thonon F, Fahmi S, Rousset-Torrente O, Bessonneau P, Griffith JW, Brown C, Chassany O, Duracinsky M.
PMID: 33949963
JMIR Res Protoc. 2021 May 05;10(5):e22239. doi: 10.2196/22239.

BACKGROUND: Late diagnoses of HIV, hepatitis B, and hepatitis C are important public health problems that affect the population at large and migrants in particular. Missed opportunities of HIV and hepatitis screening are numerous, with language differences being a...

Cite
Thonon F, Fahmi S, Rousset-Torrente O, et al. Promoting HIV, Hepatitis B Virus, and Hepatitis C Virus Screening Among Migrants With a Language Barrier: Protocol for the Development and Evaluation of an Electronic App (Apidé). JMIR Res Protoc. 2021;10(5):e22239doi: 10.2196/22239.
Thonon, F., Fahmi, S., Rousset-Torrente, O., Bessonneau, P., Griffith, J. W., Brown, C., Chassany, O., & Duracinsky, M. (2021). Promoting HIV, Hepatitis B Virus, and Hepatitis C Virus Screening Among Migrants With a Language Barrier: Protocol for the Development and Evaluation of an Electronic App (Apidé). JMIR research protocols, 10(5), e22239. https://doi.org/10.2196/22239
Thonon, Frédérique, et al. "Promoting HIV, Hepatitis B Virus, and Hepatitis C Virus Screening Among Migrants With a Language Barrier: Protocol for the Development and Evaluation of an Electronic App (Apidé)." JMIR research protocols vol. 10,5 (2021): e22239. doi: https://doi.org/10.2196/22239
Thonon F, Fahmi S, Rousset-Torrente O, Bessonneau P, Griffith JW, Brown C, Chassany O, Duracinsky M. Promoting HIV, Hepatitis B Virus, and Hepatitis C Virus Screening Among Migrants With a Language Barrier: Protocol for the Development and Evaluation of an Electronic App (Apidé). JMIR Res Protoc. 2021 May 05;10(5):e22239. doi: 10.2196/22239. PMID: 33949963; PMCID: PMC8135028.
Copy Download .nbib Format: NLM
[Critical examination of scoring systems in therapeutic trials].

Therapie

Bergmann JF, Chassany O, Segrestaa JM, Caulin C.
PMID: 7878581
Therapie. 1994 May-Jun;49(3):181-4.

Scoring systems give a check-list and methodological informations which have to be found in controlled therapeutic trials reports and papers. These systems try to quantify each item to give a global score. The Chalmer's list is the most wellknown....

Cite
Bergmann JF, Chassany O, Segrestaa JM, et al. Examen critique des grilles de lecture des essais thérapeutiques. [Critical examination of scoring systems in therapeutic trials]. Therapie. 1994;49(3):181-4
Bergmann, J. F., Chassany, O., Segrestaa, J. M., & Caulin, C. (1994). Examen critique des grilles de lecture des essais thérapeutiques. [Critical examination of scoring systems in therapeutic trials]. Therapie, 49(3), 181-4.
Bergmann, J F, et al. "Examen critique des grilles de lecture des essais thérapeutiques." [Critical examination of scoring systems in therapeutic trials]. Therapie vol. 49,3 (1994): 181-4.
Bergmann JF, Chassany O, Segrestaa JM, Caulin C. Examen critique des grilles de lecture des essais thérapeutiques. [Critical examination of scoring systems in therapeutic trials]. Therapie. 1994 May-Jun;49(3):181-4. French. PMID: 7878581.
Copy Download .nbib Format: NLM
[Letter to the editor regarding the article entitled "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France." - Reply].

La Revue de medecine interne

Péretz F, Bonini-Vuillod J, Grivaux M, Duracinsky M, Chassany O.
PMID: 33966902
Rev Med Interne. 2021 Aug;42(8):593. doi: 10.1016/j.revmed.2021.04.004. Epub 2021 May 07.

No abstract available.

Cite
Péretz F, Bonini-Vuillod J, Grivaux M, et al. Lettre à l'éditeur concernant l’article intitulé « Littérature médicale et COVID-19 : comment trois articles ont influencé les médias et la décision publique en France. » - Réponse. [Letter to the editor regarding the article entitled "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France." - Reply]. Rev Med Interne. 2021;42(8):593doi: 10.1016/j.revmed.2021.04.004.
Péretz, F., Bonini-Vuillod, J., Grivaux, M., Duracinsky, M., & Chassany, O. (2021). Lettre à l'éditeur concernant l’article intitulé « Littérature médicale et COVID-19 : comment trois articles ont influencé les médias et la décision publique en France. » - Réponse. [Letter to the editor regarding the article entitled "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France." - Reply]. La Revue de medecine interne, 42(8), 593. https://doi.org/10.1016/j.revmed.2021.04.004
Péretz, F, et al. "Lettre à l'éditeur concernant l’article intitulé « Littérature médicale et COVID-19 : comment trois articles ont influencé les médias et la décision publique en France. » - Réponse." [Letter to the editor regarding the article entitled "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France." - Reply]. La Revue de medecine interne vol. 42,8 (2021): 593. doi: https://doi.org/10.1016/j.revmed.2021.04.004
Péretz F, Bonini-Vuillod J, Grivaux M, Duracinsky M, Chassany O. Lettre à l'éditeur concernant l’article intitulé « Littérature médicale et COVID-19 : comment trois articles ont influencé les médias et la décision publique en France. » - Réponse. [Letter to the editor regarding the article entitled "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France." - Reply]. Rev Med Interne. 2021 Aug;42(8):593. doi: 10.1016/j.revmed.2021.04.004. Epub 2021 May 07. French. PMID: 33966902.
Copy Download .nbib Format: NLM
[Erratum to "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France" Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010].

La Revue de medecine interne

Péretz F, Bonini-Vuillod J, Grivaux M, Duracinsky M, Chassany O.
PMID: 33992413
Rev Med Interne. 2021 Aug;42(8):594. doi: 10.1016/j.revmed.2021.04.005. Epub 2021 May 12.

No abstract available.

Cite
Péretz F, Bonini-Vuillod J, Grivaux M, et al. Erratum à « Littérature médicale et COVID-19: comment trois articles ont influencé les médias et la décision publique en France » Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010. [Erratum to "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France" Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010]. Rev Med Interne. 2021;42(8):594doi: 10.1016/j.revmed.2021.04.005.
Péretz, F., Bonini-Vuillod, J., Grivaux, M., Duracinsky, M., & Chassany, O. (2021). Erratum à « Littérature médicale et COVID-19: comment trois articles ont influencé les médias et la décision publique en France » Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010. [Erratum to "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France" Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010]. La Revue de medecine interne, 42(8), 594. https://doi.org/10.1016/j.revmed.2021.04.005
Péretz, F, et al. "Erratum à « Littérature médicale et COVID-19: comment trois articles ont influencé les médias et la décision publique en France » Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010." [Erratum to "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France" Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010]. La Revue de medecine interne vol. 42,8 (2021): 594. doi: https://doi.org/10.1016/j.revmed.2021.04.005
Péretz F, Bonini-Vuillod J, Grivaux M, Duracinsky M, Chassany O. Erratum à « Littérature médicale et COVID-19: comment trois articles ont influencé les médias et la décision publique en France » Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010. [Erratum to "COVID-19 and medical publications: How three articles have influenced the media and public decisions in France" Rev Med Interne 42 (2021) 10.1016/j.revmed.2021.03.010]. Rev Med Interne. 2021 Aug;42(8):594. doi: 10.1016/j.revmed.2021.04.005. Epub 2021 May 12. French. PMID: 33992413; PMCID: PMC8114148.
Copy Download .nbib Format: NLM
[Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives].

Bulletin de l'Academie nationale de medecine

Leger JM, Bombelli F, Tran-Thanh H, Chassande B, Maisonobe T, Viala K.
PMID: 21568049
Bull Acad Natl Med. 2010 Apr-May;194(4):753-64; discussion 764-5.

Since the first description of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP) by PJ Dyck's group at the Mayo Clinic 35 years ago, a wide range of publications have underlined the clinical, electrophysiologic and histopathologic heterogeneity of this disease. Expert consensus...

Cite
Leger JM, Bombelli F, Tran-Thanh H, et al. Polyneuropathies inflammatoires démyélinisantes chroniques: hétérogénéité clinique et difficultés thérapeutiques. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives]. Bull Acad Natl Med. 2010;194(4):753-64; discussion 764-5
Leger, J. M., Bombelli, F., Tran-Thanh, H., Chassande, B., Maisonobe, T., & Viala, K. (2010). Polyneuropathies inflammatoires démyélinisantes chroniques: hétérogénéité clinique et difficultés thérapeutiques. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives]. Bulletin de l'Academie nationale de medecine, 194(4), 753-64; discussion 764-5.
Leger, Jean-Marc, et al. "Polyneuropathies inflammatoires démyélinisantes chroniques: hétérogénéité clinique et difficultés thérapeutiques." [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives]. Bulletin de l'Academie nationale de medecine vol. 194,4 (2010): 753-64; discussion 764-5.
Leger JM, Bombelli F, Tran-Thanh H, Chassande B, Maisonobe T, Viala K. Polyneuropathies inflammatoires démyélinisantes chroniques: hétérogénéité clinique et difficultés thérapeutiques. [Chronic inflammatory demyelinating polyradiculoneuropathy: clinical heterogeneity and therapeutic perspectives]. Bull Acad Natl Med. 2010 Apr-May;194(4):753-64; discussion 764-5. French. PMID: 21568049.
Copy Download .nbib Format: NLM
[Not Available].

Therapie

Lemaire F, Marchenay B, Chassany O, Barthélémy P, Bouzzagou M, Comet D, Delval C, Dubray C, Fouret C, Frija-Orvoen E, Gambotti L, Lamarque V, d'Orsay G, Plattner V, Sibenaler C, Roux J, Thoby F.
PMID: 27393394
Therapie. 2015 Jan-Feb;70(1):21-8. doi: 10.2515/therapie/2014229.

No abstract available.

Cite
Lemaire F, Marchenay B, Chassany O, et al. Le règlement européen « essais cliniques » : articulation avec la loi Jardé : un atelier de Giens. [Not Available]. Therapie. 2015;70(1):21-8doi: 10.2515/therapie/2014229.
Lemaire, F., Marchenay, B., Chassany, O., Barthélémy, P., Bouzzagou, M., Comet, D., Delval, C., Dubray, C., Fouret, C., Frija-Orvoen, E., Gambotti, L., Lamarque, V., d'Orsay, G., Plattner, V., Sibenaler, C., Roux, J., & Thoby, F. (2015). Le règlement européen « essais cliniques » : articulation avec la loi Jardé : un atelier de Giens. [Not Available]. Therapie, 70(1), 21-8. https://doi.org/10.2515/therapie/2014229
Lemaire, François, et al. "Le règlement européen « essais cliniques » : articulation avec la loi Jardé : un atelier de Giens." [Not Available]. Therapie vol. 70,1 (2015): 21-8. doi: https://doi.org/10.2515/therapie/2014229
Lemaire F, Marchenay B, Chassany O, Barthélémy P, Bouzzagou M, Comet D, Delval C, Dubray C, Fouret C, Frija-Orvoen E, Gambotti L, Lamarque V, d'Orsay G, Plattner V, Sibenaler C, Roux J, Thoby F. Le règlement européen « essais cliniques » : articulation avec la loi Jardé : un atelier de Giens. [Not Available]. Therapie. 2015 Jan-Feb;70(1):21-8. doi: 10.2515/therapie/2014229. French. PMID: 27393394.
Copy Download .nbib Format: NLM
Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation.

Patient preference and adherence

Benzimra M, Bonnamour B, Duracinsky M, Lalanne C, Aubert JP, Chassany O, Aubin-Auger I, Mahé I.
PMID: 29379275
Patient Prefer Adherence. 2018 Jan 04;12:79-87. doi: 10.2147/PPA.S131158. eCollection 2018.

INTRODUCTION: Direct oral anticoagulants (DOACs) have shown noninferiority to vitamin K antagonists (VKA) in stroke prevention in patients with atrial fibrillation. DOAC treatment may be less demanding than VKA, improving quality of life. To date, there have been no...

Cite
Benzimra M, Bonnamour B, Duracinsky M, et al. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation. Patient Prefer Adherence. 2018;12:79-87doi: 10.2147/PPA.S131158.
Benzimra, M., Bonnamour, B., Duracinsky, M., Lalanne, C., Aubert, J. P., Chassany, O., Aubin-Auger, I., & Mahé, I. (2018). Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation. Patient preference and adherence, 1279-87. https://doi.org/10.2147/PPA.S131158
Benzimra, Michaël, et al. "Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation." Patient preference and adherence vol. 12 (2018): 79-87. doi: https://doi.org/10.2147/PPA.S131158
Benzimra M, Bonnamour B, Duracinsky M, Lalanne C, Aubert JP, Chassany O, Aubin-Auger I, Mahé I. Real-life experience of quality of life, treatment satisfaction, and adherence in patients receiving oral anticoagulants for atrial fibrillation. Patient Prefer Adherence. 2018 Jan 04;12:79-87. doi: 10.2147/PPA.S131158. eCollection 2018. PMID: 29379275; PMCID: PMC5757966.
Copy Download .nbib Format: NLM
Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism.

Patient preference and adherence

Keita I, Aubin-Auger I, Lalanne C, Aubert JP, Chassany O, Duracinsky M, Mahé I.
PMID: 29026288
Patient Prefer Adherence. 2017 Sep 25;11:1625-1634. doi: 10.2147/PPA.S131157. eCollection 2017.

INTRODUCTION: Direct oral anticoagulants (DOACs) have shown non-inferiority and ease of use compared to vitamin K antagonists (VKA) in the treatment of venous thromboembolism (VTE). No study so far has been directed toward real-life experience of outpatients receiving anticoagulants...

Cite
Keita I, Aubin-Auger I, Lalanne C, et al. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism. Patient Prefer Adherence. 2017;11:1625-1634doi: 10.2147/PPA.S131157.
Keita, I., Aubin-Auger, I., Lalanne, C., Aubert, J. P., Chassany, O., Duracinsky, M., & Mahé, I. (2017). Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism. Patient preference and adherence, 111625-1634. https://doi.org/10.2147/PPA.S131157
Keita, Ingre, et al. "Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism." Patient preference and adherence vol. 11 (2017): 1625-1634. doi: https://doi.org/10.2147/PPA.S131157
Keita I, Aubin-Auger I, Lalanne C, Aubert JP, Chassany O, Duracinsky M, Mahé I. Assessment of quality of life, satisfaction with anticoagulation therapy, and adherence to treatment in patients receiving long-course vitamin K antagonists or direct oral anticoagulants for venous thromboembolism. Patient Prefer Adherence. 2017 Sep 25;11:1625-1634. doi: 10.2147/PPA.S131157. eCollection 2017. PMID: 29026288; PMCID: PMC5626412.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 17 entries